Skip to main content

Celebrex News

Health Issue Has Bruce Springsteen Postponing Shows for the Rest of the Year

THURSDAY, Sept. 28, 2023 – Rock star Bruce Springsteen announced Wednesday that he has postponed all of his remaining shows this year as he deals with peptic ulcer disease. Springsteen said he’s c...

FDA Medwatch Alert: Drug Safety Communication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later

ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding...

FDA Approves Consensi (amlodipine and celecoxib) for Treatment of Hypertension and Osteoarthritis Pain

TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) – Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration...

FDA Medwatch Alert: Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke

[Posted 07/09/2015] ISSUE:  FDA is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on ...

FDA Medwatch Alert: Celebrex (celecoxib) - Apr 7, 2005

After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the market. This request is based on: *...

FDA Medwatch Alert: Celebrex (celecoxib) - Jun 15, 2005

FDA has requested that sponsors of all non-steroidal anti-inflammatory drugs (NSAID) make labeling changes to their products. FDA recommended proposed labeling for both the prescription and...

FDA Medwatch Alert: Celebrex (celecoxib) - Dec 21, 2004

FDA notified healthcare professionals that, based on emerging information, including preliminary reports from one of several long term National Institutes of Health (NIH) prevention studies, the risk...

FDA Medwatch Alert: COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

After concluding that the overall risk versus benefit profile is unfavorable, FDA has requested Pfizer, Inc. to voluntarily withdraw Bextra (valdecoxib) from the market. This request is based on: *...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Ankylosing Spondylitis, Osteoarthritis, Juvenile Rheumatoid Arthritis, Pain, Period Pain, Dysmenorrhea, Rheumatoid Arthritis

Celebrex patient information at Drugs.com